Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2003
08/14/2003WO2003066001A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
08/14/2003WO2003065999A2 Proliferated cell lines and uses thereof
08/14/2003WO2003065997A2 Anti-infarction molecules
08/14/2003WO2003065994A2 Schwann cell and phosphodiesterase inhibitors based therapy
08/14/2003WO2003065992A2 Treating benign prostate hyperplasia with sarms
08/14/2003WO2003065991A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
08/14/2003WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
08/14/2003WO2003065988A2 A combination for treating cold and cough
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003065982A2 Engineering absorption of therapeutic compounds via colonic transporters
08/14/2003WO2003065980A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003WO2003065974A2 Hexa-, hepta-, and octapeptides having antiangiogenic activity
08/14/2003WO2003065971A2 Non-myeloablative tolerogenic treatment with tyrphostins
08/14/2003WO2003065970A2 Treatment of fibromyalgia and related fatigue syndromes using pindolol
08/14/2003WO2003065806A1 New immunoeffector compounds
08/14/2003WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003WO2003043647A3 A plant extract active as an immunostimulating agent
08/14/2003WO2003033499A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003030935A3 Adjuvants for nucleic acid vaccines
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003013655A3 Carbonic anhydrase inhibitors
08/14/2003WO2003012051A8 Inhibitor of dna methylation
08/14/2003WO2003002129B1 Use of sulodexide for the treatment of inflammatory bowel disease
08/14/2003WO2003000202A3 Particles for inhalation having rapid release properties
08/14/2003WO2002092849A3 Methods
08/14/2003WO2002081430A3 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
08/14/2003WO2002081005A3 Peritoneal dialysis fluid
08/14/2003WO2002058733B1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
08/14/2003WO2002052036A3 Identification of modulators of dham-kinase and inflammatory diseases
08/14/2003WO2002051438A3 Use of repulsive guidance molecule (rgm) and its modulators
08/14/2003WO2002043807A3 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction
08/14/2003WO2002024887A3 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002020475A3 Inhibitors of serine protease activity of matriptase or mtsp1
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001092292A3 Ghrelin analogs
08/14/2003WO2001090421A3 Method of detecting inflammatory lung disorders
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003US20030153849 Method and apparatus for connective tissue treatment
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153756 Pyrimido[5,4-e] [1,2,4]triazine-5, 7-diamine compounds as protein tyrosine phosphatase inhibitors
08/14/2003US20030153755 Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases
08/14/2003US20030153750 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/14/2003US20030153732 Novel polypepetide
08/14/2003US20030153628 Aldose reductase inhibitors and pharmaceutical compositions
08/14/2003US20030153627 Compounds for blocking androgen receptors
08/14/2003US20030153625 Suppressing bone disordes such as decalcification or fractures in humans having prostate gland cancers by administering antiestrogen selected from triphenylethylene or toremifene; hormone inhibitors
08/14/2003US20030153615 Novel compositions and uses of dictyostatin compounds
08/14/2003US20030153610 Substituted oxazolidinones and their in the field of blood coagulation
08/14/2003US20030153605 Enzyme inhibitors of nitric oxide synthase
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153600 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis
08/14/2003US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders
08/14/2003US20030153588 Such as N-butyl-2-(4-(4-chloro-3-methoxyphenyl)-5-pyridin-4-yl-1H-imidazole-2 -yl)isobutylamide for treatment of neurotraumatic disorders
08/14/2003US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
08/14/2003US20030153583 Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole
08/14/2003US20030153580 Cis-imidazolines
08/14/2003US20030153578 CCR-3 receptor antagonists (I)
08/14/2003US20030153576 Such as amino-indazoles for treatment of central nervous system disorders
08/14/2003US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors
08/14/2003US20030153569 Novel pyrazole and pyrazoline substituted compounds
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153566 Adenosine receptor agonist
08/14/2003US20030153563 CRF receptor antagonists and methods relating thereto
08/14/2003US20030153561 Pyrroloquinolones as antiviral agents
08/14/2003US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides
08/14/2003US20030153558 Immunomodulators and/or inhibiting cytokine release
08/14/2003US20030153557 Treating osteoporosis, cardiovascular disorders, restenosis, arteriosclerosis, nephropathies or retinopathies; antitumor and antiinflammatory agents
08/14/2003US20030153553 Quinoline derivatives
08/14/2003US20030153549 Clavulinic acid derivatives; antibiotics
08/14/2003US20030153539 Use of estramustine phosphate or a metabolite thereof in preparation of anticarcinogenic agent
08/14/2003US20030153530 Solubility enhancing component other than a cyclodextrin, particularly a polyanionic component, an oxy-chloro component to aid in preserving the composition, liquid carrier
08/14/2003US20030153529 Dextrin containing compositions for prevention of adhesions
08/14/2003US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states
08/14/2003US20030153524 Including extracellular matrix production and/or deposition, neovascularization, inflammation, cell proliferation, cell migration, associated with connective tissue growth factor by administering agent that decreases expression of the factor
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153519 Drug delivering a nucleic acid and an RNase inhibitor to a target cell of a vascularized multi-cellular organism; RNA interference
08/14/2003US20030153513 Preventives or remedies for obesity or fatty liver
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003US20030153506 Anticoagulant therapy; multicompartment kits, synergistic effect using the mixtures
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153502 A water-soluble polypeptide having hydrophobic side chains, for use as bactericides treating infections, detoxification of endotoxin, cell antiproliferative agents, antagonist of tumor necrosis factor
08/14/2003US20030153497 A polypeptides and polynucleotides encoding the polypeptides, for obesity, insulin resistance, type 2 diabetes, cachexia
08/14/2003US20030153492 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
08/14/2003US20030153489 Agent for preventing and/or treating multiple organ failure
08/14/2003US20030153082 An isolated population of human hematopoietic cells that proliferates in culture, obtained by differentiating primate pluripotent stem (pPS) cells, and atleast 1% cells are CD45 + and population forms colonies
08/14/2003US20030153081 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/14/2003US20030153075 TGF-beta-specific covalently closed antisense molecule
08/14/2003US20030153074 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
08/14/2003US20030153072 Culturing spermatogonial stem cells in the presence of BMP8 (bone morphogenetic protein-8) or a biologically active fragment or an agonist to effect proliferation of mammal spermatogonial stem cells
08/14/2003US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders
08/14/2003US20030153040 Central nervous system disorders; antiinflammatory agents; antidiabetic agents; anticancer agents; hybrid polynucleotide
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/14/2003US20030152653 Echinacea supplement and method of manufacture
08/14/2003US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof
08/14/2003US20030152645 Aqueous ionic solutions and their uses in particular in ophthlamology
08/14/2003US20030152637 Administering by injection; glycolic acid-lactic acid copolymer; sustained release particles
08/14/2003US20030152626 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders
08/14/2003US20030152615 Enhanced drug delivery in transdermal systems
1 ... 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 ... 1564